Short Selling RIGL (Rigel Pharmaceuticals) – $800

Short Selling RIGL (Rigel Pharmaceuticals) stock despite positive news.

Even though RIGL (Rigel Pharmaceuticals) was granted FDA approval and an analyst price target increase, it was still a short due to technical over-extension and a 200M offering registered two weeks prior.

Leave a Reply

Your email address will not be published.